Trial · NCT00299104
Participant flow39
How many started, completed or left each group, period by period.
1 to 20 of 39
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Period | STARTED | Placebo + Methotrexate | 251 | |
| Treatment Period | STARTED | Rituximab (0.5 g x 2) + Methotrexate | 252 | |
| Treatment Period | STARTED | Rituximab (1.0 g x 2) + Methotrexate | 252 | |
| Treatment Period | Safety/ITT: Received Study Drug | Placebo + Methotrexate | 249 | |
| Treatment Period | Safety/ITT: Received Study Drug | Rituximab (0.5 g x 2) + Methotrexate | 249 | |
| Treatment Period | Safety/ITT: Received Study Drug | Rituximab (1.0 g x 2) + Methotrexate | 250 | |
| Treatment Period | Completed Week 24 | Placebo + Methotrexate | 227 | |
| Treatment Period | Completed Week 24 | Rituximab (0.5 g x 2) + Methotrexate | 240 | |
| Treatment Period | Completed Week 24 | Rituximab (1.0 g x 2) + Methotrexate | 241 | |
| Treatment Period | Completed Week 52 | Placebo + Methotrexate | 213 | |
| Treatment Period | Completed Week 52 | Rituximab (0.5 g x 2) + Methotrexate | 227 | |
| Treatment Period | Completed Week 52 | Rituximab (1.0 g x 2) + Methotrexate | 232 | |
| Treatment Period | Completed Week 104 | Placebo + Methotrexate | 178 | |
| Treatment Period | Completed Week 104 | Rituximab (0.5 g x 2) + Methotrexate | 213 | |
| Treatment Period | Completed Week 104 | Rituximab (1.0 g x 2) + Methotrexate | 216 | |
| Treatment Period | COMPLETED | Placebo + Methotrexate | 62 | |
| Treatment Period | COMPLETED | Rituximab (0.5 g x 2) + Methotrexate | 77 | |
| Treatment Period | COMPLETED | Rituximab (1.0 g x 2) + Methotrexate | 80 | |
| Treatment Period | NOT COMPLETED | Placebo + Methotrexate | 189 | |
| Treatment Period | NOT COMPLETED | Rituximab (0.5 g x 2) + Methotrexate | 175 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00299104/flow